...
首页> 外文期刊>International Scholarly Research Notices >Solubility Enhancement of Etoricoxib by Cosolvency Approach
【24h】

Solubility Enhancement of Etoricoxib by Cosolvency Approach

机译:溶解度法提高依托昔布的溶解度

获取原文

摘要

The purpose of the present study was to examine and compare the cosolvency using three different cosolvents, namely PEG 400, PG, and glycerin on the aqueous solubility enhancement of a poorly aqueous soluble drug, etoricoxib, since solubilization of nonpolar drugs constitutes one of the important tasks in the formulation design of liquid dosage forms. The aqueous solubility of etoricoxib was0.0767±0.0018 mg/mL, which was significantly improved by the addition of PEG 400, PG, and glycerin as cosolvents. It was scrutinized that the less-polar solvents were found to increase the aqueous solubility by greater extent, thus accentuating hydrophobic interaction mechanism. Among various solvent-cosolvent blends investigated, water-PEG 400 showed highest solubilization potential. Thus, the study generated an important array of data to compare the effect of these cosolvents on the aqueous solubility of etoricoxib.
机译:本研究的目的是检查和比较使用三种不同的助溶剂PEG 400,PG和甘油对难溶于水的药物依托考昔的水溶解度提高的共溶性,因为非极性药物的增溶构成重要的药物之一液体剂型配方设计中的任务。依托昔布的水溶解度为0.0767±0.0018 / mg / mL,通过加入PEG 400,PG和甘油作为助溶剂可以显着提高其溶解度。仔细检查发现,发现极性较小的溶剂在更大程度上增加了水溶性,从而增强了疏水相互作用的机理。在研究的各种溶剂-助溶剂共混物中,水-PEG 400显示出最高的增溶潜力。因此,该研究产生了重要的数据,以比较这些助溶剂对依托考昔的水溶性的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号